BioPharmSignal logoBioPharmSignal

Biotech News

OPKO Health to Participate in the Wells Fargo 21st Annual Healthcare Conference

Bio-Reference Laboratories (BRLI)Bio-Reference LaboratoriesConference / presentation

MIAMI, Sept. 08, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) , a fully-integrated healthcare company focused on delivering next-generation solutions for serious diseases across established global markets, today announced that Elias A. Zerhouni, M.D., President and Vice Chairman, and Adam Logal, Senior Vice President and Chief Financial Officer, will participate in the Wells Fargo 21st Annual Healthcare Conference at the Encore Boston Harbor, including a fireside chat on Thursday, September 10, 2026, at 9:30 a.m. ET.

A webcast and replay of the fireside chat can be accessed from the OPKO IR website .

About OPKO Health

OPKO is a multinational biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large, rapidly growing markets by leveraging its discovery, development and commercialization expertise, and novel and proprietary technologies. For more information, please visit www.opko.com.

Contacts: Alliance Advisors IR Vivian Cervantes, 973-873-7724 [email protected]

Source: OPKO Health, Inc. Released September 8, 2026

Related news

LUCDLucid Diagnostics2026-04-09 12:01 EST

Lucid Diagnostics to Participate in Fireside Chat at the 25th Annual Needham Virtual Healthcare Conference

BIAFbioAffinity Technologies, Inc.2026-09-03 20:30 EST

bioAffinity Technologies to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

DGXQuest Diagnostics2026-08-25 13:30 EST

Quest Diagnostics to Speak at the Baird 2026 Global Healthcare Conference

DGXQuest Diagnostics2026-08-24 13:00 EST

Quest Diagnostics to Speak at the Morgan Stanley 24th Annual Global Healthcare Conference

BDSXBiodesix2026-08-04 10:00 EST

Biodesix to Participate in Canaccord Genuity’s 46th Annual Growth Conference

XGNExagen2026-07-28 13:00 EST

Exagen Inc. to Participate in Upcoming Investor Conference

INBSIntelligent Bio Solutions2026-06-04 12:30 EST

Intelligent Bio Solutions to Participate in Planet MicroCap Las Vegas Conference over June 16-18

BRLIBio-Reference Laboratories2026-08-13 13:15 EST

OPKO Health Expands Strategic Relationship with HealthCare Royalty Through $125 Million Notes Issuance Secured by Mazdutide Royalty Interests

BJDXBluejay Diagnostics2026-03-12 10:30 EST

Bluejay Announces Abstract Accepted for Presentation at the 2026 Society of Academic Emergency Medicine (SAEM) Annual Meeting

BRLIBio-Reference Laboratories2026-07-27 20:05 EST

OPKO Health Reports Second Quarter 2026 Business Highlights and Financial Results

View all latest news

Bio-Reference Laboratories

Diversified Healthcare and Diagnostics Platform The source release primarily describes OPKO Health, a multinational biopharmaceutical and diagnostics company with laboratory services, specialty testing, commercial medicines, and multiple clinical-stage programs. BioReference-related diagnostics, commercial products, and the ModeX...

Recent company news

BRLIBio-Reference Laboratories2026-09-08 17:55 EST

OPKO Health to Participate in the Wells Fargo 21st Annual Healthcare Conference

BRLIBio-Reference Laboratories2026-08-13 13:15 EST

OPKO Health Expands Strategic Relationship with HealthCare Royalty Through $125 Million Notes Issuance Secured by Mazdutide Royalty Interests

BRLIBio-Reference Laboratories2026-07-27 20:05 EST

OPKO Health Reports Second Quarter 2026 Business Highlights and Financial Results

BRLIBio-Reference Laboratories2026-07-23 16:30 EST

OPKO Health to Report Second Quarter 2026 Financial Results on July 27, 2026

BRLIBio-Reference Laboratories2026-06-15 12:00 EST

Preclinical Data for OPKO Biologics' OPK8801001 in Acromegaly Presented at ENDO 2026

Stock data

Close
—
Market cap
—
Exchange
NASDAQ
Sector
MedTech
Location
United States